Nanolive has released it’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data – ranging from T cell activation to target cell interactions and killing.
Watch the product release, where we showcase the versatility of the LIVE T Cell Assay through case studies featuring CAR-T and bispecific antibody screening, highlighting the assay’s ability to characterize immunotherapeutic specificity, robustness, and efficacy, as well as its value across different stages of preclinical research and development.
Read our latest news
Newsletter June: From live cells to insights: Streamline immunotherapy discovery without labels
Welcome to the June edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
Newsletter May: From live cells to insights: Explore AI-Powered Immune Profiling
Welcome to the May edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live cell...
Newsletter April: AI-powered, label-free toxicology – Beyond animal testing
Welcome to the April edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live-cell...